Searchable abstracts of presentations at key conferences in endocrinology

ea0022p14 | Adrenal | ECE2010

Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate as markers of disease severity in community-acquired pneumonia

Blum Claudine A , Schuetz Philipp , Stolz Daiana , Bingisser Roland , Mueller Christian , Tamm Michael , Trummler Michael , Mueller Beat , Christ-Crain Mirjam

Background: Rapid and accurate risk stratification in patients with community-acquired pneumonia (CAP) is an unmet clinical need. Cortisol to DHEA ratio was put forward as a prognostic marker in sepsis. We herein validated the prognostic value of DHEA and DHEAS and of cortisol/DHEA- and cortisol-DHEAS – ratios, respectively, in patients with CAP as the most common (disease resulting) sepsis-defining illness.Methods: We assessed clinical parameters a...

ea0016p450 | Neuroendocrinology | ECE2008

The benefit of long-term growth hormone replacement therapy in adults, results of the German KIMS database

Albrecht Christin , Buchfelder Michael , Faszbender Walter , Faust Michael , Kann Peter , Kreitschmann-Andermahr Ilonka , Kohlmann Thomas , Koltowska-Haggstrom Maria , Wallaschofski Henri

Objective: The German KIMS Database is a national surveillance study for evaluation of efficacy and safety of growth hormone (GH) replacement therapy in adults with GH deficiency (GHD) in clinical practice.Patients: The analysis was performed using data of 1425 consecutively documented adult patients (777 men, 648 women) with GHD enrolled in KIMS Germany. The present report examined baseline and long term data (>48 months, range: 48–161 month) f...

ea0014p261 | (1) | ECE2007

Hepatic and brain metabolism in young adults with glycogen storage disease type 1

Mandl Martina , Weghuber Daniel , Krssak Martin , Roden Michael , Nowotny Peter , Brehm Atilla , Krebs Michael , Widhalm Kurt , Bischof Martin

Glycogen storage disease type 1 (GSD1) is a rare inherited defect of endogenous glucose production. While children present with severe hypoglycemia the propensity for hypoglycemia may decrease with age in these patients. It was the aim of this study to elucidate the mechanisms for milder hypoglycemia symptoms in grown up GSD1 patients. Four patients with GSD1 (BMI: 23.2±6.3 kg/m2, age: 21±3 yr) and four healthy controls matched for BMI (23.1±3.0 kg/m<...

ea0013oc22 | Novartis Basic Endocrinology Award | SFEBES2007

Mice deleted for a Multiple Endocrine Neoplasia Type 1 (MEN1) allele develop pancreatic, pituitary and parathyroid tumours in association with hypercalcaemia

Lemos Manuel , Harding Brian , Bowl Michael , Reed Anita , Tateossian Hilda , Hough Tertius , Fraser William , Cheeseman Michael , Thakker Rajesh

Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by the combined occurrence of tumours of the parathyroids, pancreas and pituitary. The MEN1 gene, which is located on chromosome 11q13 and encodes a 610 amino acid protein (menin), belongs to the class of tumour suppressors. To investigate the role of menin in tumour suppression, three different mouse models have been generated through targeted disruption of the Men1 gene. ...

ea0099p527 | Pituitary and Neuroendocrinology | ECE2024

Soluble alpha klotho concentrations are resistant to short-term stimulation and suppression of growth hormone

Ribeiro de Oliveira Longo Schweizer Junia , Schilbach Katharina , Tausendfreund Olivia , Haenelt Michael , Gagliardo Anica , Schopohl Jochen , Drey Michael , Bidlingmaier Martin

Background: Serum soluble alpha klotho (sαKL) is a circulating protein which had been shown to be very high in active acromegaly, and significantly reduced after disease control. Therefore, sαKL has been suggested as a new biomarker for growth hormone (GH) excess. In this study, we aimed to evaluate the impact of short-term stimulation and suppression of GH and acute modulation of glucose metabolism on sαKL concentrations.Methods: Serum s&...

ea0081p245 | Late-Breaking | ECE2022

Recalculating renin and aldosterone to improve specificity in the diagnosis of primary aldosteronism

Doyle Luc , Okiro Julie , Sarwani Aysha , Troy Michael , Ansari Yousef , O′Donoghue Darragh , Lappin David , Mcevoy John , O'Shea Paula , Ferguson John , Conall Dennedy Michael

Rationale: The Aldosterone:Renin ratio (ARR) is commonly used for patients fulfilling screening criteria for primary hyperaldosteronism (PA), followed by confirmatory testing. Reference intervals for interpretation of the ARR vary in accordance with local population and assay 1. While ARR provides high sensitivity for PA, this is compromised by low specificity, further compounded by medication interference. However, additional variables may improve the specificity of ARR as a ...

ea0047oc14 | Spotlight on Neuroendocrine tumours | Theranostics2016

68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors – a head-to-head comparison with DOTATOC and FDG PET/CT

Lassmann Michael , Werner Rudolf A. , Weich Alexander , Wester Hans-Juergen , Scheurlen Michael , Higuchi Takahiro , Samnick Samuel , Bluemel Christina , Rudelius Martina , Buck Andreas K. , Lapa Constantin , Herrmann Ken

Introduction: Diagnostic imaging of neuroendocrine tumors (NETs) is the domain of somatostatin receptor (SSTR) agonists as well as FDG PET/CT in dedifferentiated tumors. SSTR also serves as target for receptor directed peptide therapy. More recently, specific ligands targeting the chemokine receptor 4 (CXCR4) were introduced potentially offering an additional theranostic option in NETs. Here we evaluated the CXCR4 expression using 68Ga-Pentixafor PET/CT in NET patie...

ea0037oc3.5 | Calcium, vitamin D and bone | ECE2015

Three-year safety and efficacy data for recombinant human parathyroid hormone, rhPTH(1-84), in the treatment of adults with hypoparathyroidism: the RACE study

Clarke Bart L , Mannstadt Michael , Vokes Tamara J , Rothman Jeffrey , Warren Mark L , Denham Douglas S , Levine Michael A , Lagast Hjalmar , Bilezikian John P , Shoback Dolores M

Hypoparathyroidism is a rare endocrine deficiency due to inadequate amounts of parathyroid hormone (PTH) and is characterised by hypocalcaemia and hyperphosphataemia. Current management regimens with large amounts of oral calcium and active vitamin D do not adequately control mineral homeostasis and can lead to complications in many patients. The phase III REPLACE and RELAY clinical trials established the efficacy and safety of once-daily s.c. injection of r...

ea0073aep644 | Thyroid | ECE2021

Assessment of clinical burden and practice patterns in patients with chronic hypoparathyroidism in the united states (us): a claims data analysis using diagnosis-based criteria

Sharma Dolly , L Deering Kathleen , Allas Soraya , Culler Michael D. , Loustau Patrick , Weiss Blandine , Michelle Mitchell Deborah , Astolfi Danette , Mannstadt Michael

ObjectivesThere is a paucity of real-world studies analyzing comorbidities, lab testing and treatment patterns of patients with chronic hypoparathyroidism (cHP). This study describes a large cohort of cHP patients identified using a diagnosis-based approach from a US claims database.MethodsThis retrospective study was conducted using a large (130 million individuals) claims database (HealthVerity Closed Payer...

ea0073ep226 | Thyroid | ECE2021

Assessment of clinical burden and practice patterns in patients with chronic hypoparathyroidism in the United States (US): A claims data analysis using a surgery-based approach

Sharma Dolly , L Deering Kathleen , Loustau Patrick , Michael D. Culler , Allas Soraya , Weiss Blandine , Michelle Mitchell Deborah , Astolfi Danette , Mannstadt Michael

ObjectivesThere is a paucity of real-world studies on the clinical burden and practice patterns associated with chronic hypoparathyroidism (cHP). This study assesses the comorbidities, treatment and lab testing patterns in cHP patients identified using surgery-based criteria.MethodsThis was a retrospective study conducted using a large (130 million individuals) US claims database (HealthVerity Closed Payer Cl...